News

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...
Certain symptoms of menopause get more attention than others. Most people are aware that hot flashes and night sweats can ...
When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.
How a Naturopath in St. Catharines Addresses the Root Causes” by Dr. Aoife Earls, ND, explores the deeper reasons behind ...
Several non-hormonal medications may help. “Gabapentin and Clonidine help minimize hot flashes by working with ... review and network meta-analysis of treatment effects from the National ...
The California legislature wants doctors to get more educated about menopause symptoms and treatment, part of a national ...